ConductScience.org, home

Paper29620187

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

Tang G and 7 others. Int J Oncol, 2018. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation. Papers, record 29620187. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29620187

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.
PubMed
Journal
Int J Oncol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.39
iCite
Revised in PubMed
2021-12-04
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tang GGuiju
2Guo JJianfeng
3Zhu YYapei
4Huang ZZaiju
5Liu TTing
6Cai JJing
7Yu LLili
8Wang ZZehua

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HistonesMajor topic
MetforminMajor topic
Ovarian NeoplasmsMajor topic
Polycomb Repressive Complex 2Major topic
Protein KinasesMajor topic
AMP-Activated Protein Kinase Kinases
Cell Line, Tumor
Cell Movement
Cell Proliferation
Cell Survival
Epigenesis, Genetic
Female
Humans
Methylation
Phosphorylation

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126794276Measuring the biological effect of presurgical metformin treatment in endometrial cancer.Br J Cancer2016https://conductscience.org/library/papers/26794276PubMed
228620234EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.Sci Rep2017https://conductscience.org/library/papers/28620234PubMed
322643892Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.Nat Commun2012https://conductscience.org/library/papers/22643892PubMed
424460896The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.Diabetes Obes Metab2014https://conductscience.org/library/papers/24460896PubMed
520944598Epigenetic modifications and human disease.Nat Biotechnol2010https://conductscience.org/library/papers/20944598PubMed
623352629Association of metformin use with cancer incidence and mortality: a meta-analysis.Cancer Epidemiol2013https://conductscience.org/library/papers/23352629PubMed
715196462The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.Curr Opin Genet Dev2004https://conductscience.org/library/papers/15196462PubMed
822266734Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.Diabetes Care2012https://conductscience.org/library/papers/22266734PubMed
925663310Autophagy and protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α) pathway protect ovarian cancer cells from metformin-induced apoptosis.Mol Carcinog2016https://conductscience.org/library/papers/25663310PubMed
1022337149The insulin and insulin-like growth factor receptor family in neoplasia: an update.Nat Rev Cancer2012https://conductscience.org/library/papers/22337149PubMed
1111846609Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods2001https://conductscience.org/library/papers/11846609PubMed
1227681864Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.Ann Oncol2016https://conductscience.org/library/papers/27681864PubMed
1325368099Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes.Diabetes2015https://conductscience.org/library/papers/25368099PubMed
1424985407Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Cancer Prev Res (Phila)2014https://conductscience.org/library/papers/24985407PubMed
1528289190AMPK blocks starvation-inducible transgenerational defects in Caenorhabditis elegans.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28289190PubMed
1626277279Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity.Pharmacol Res2015https://conductscience.org/library/papers/26277279PubMed
1722809961Metformin is synthetically lethal with glucose withdrawal in cancer cells.Cell Cycle2012https://conductscience.org/library/papers/22809961PubMed
1827517917The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.Int J Mol Sci2016https://conductscience.org/library/papers/27517917PubMed
1924607285"Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit?Gynecol Oncol2014https://conductscience.org/library/papers/24607285PubMed
2022964433SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.Mol Cancer Res2012https://conductscience.org/library/papers/22964433PubMed

See all 46 referencesDownload CSV of references

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
42649936Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies.Cancers (Basel)2026https://conductscience.org/library/papers/42649936PubMed
42193942Combined Effect of Metformin and miR-145/miR-23b Co-Transfection on Proliferation and Progression in 2D and 3D Epithelial Ovarian Cancer Models.Cells2026https://conductscience.org/library/papers/42193942PubMed
41897350Metformin-A Type 2 Diabetes Mellitus Drug-And Ovarian Cancer: Anticancer Mechanisms and Therapeutic Implications.Biomolecules2026https://conductscience.org/library/papers/41897350PubMed
41041224The role of epigenetics in cancer: From pathways to the clinic.J Family Med Prim Care2025https://conductscience.org/library/papers/41041224PubMed
40190675Maternal Metformin Administration During the Pre-Gestation Period Improves Transient Cerebral Ischemia Injury in Male Offspring Rats.Adv Pharm Bull2024https://conductscience.org/library/papers/40190675PubMed
40005128The Anti-Aging Mechanism of Metformin: From Molecular Insights to Clinical Applications.Molecules2025https://conductscience.org/library/papers/40005128PubMed
39595655Anti-Diabetic Therapies and Cancer: From Bench to Bedside.Biomolecules2024https://conductscience.org/library/papers/39595655PubMed
39562830Dietary phytosterols induce infertility in female mice via epigenomic modulations.Commun Biol2024https://conductscience.org/library/papers/39562830PubMed
39115639Assessing the antitumor effects of metformin on ovarian clear cell carcinoma.Hum Cell2024https://conductscience.org/library/papers/39115639PubMed
38981246Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway.Transl Oncol2024https://conductscience.org/library/papers/38981246PubMed
38962452Bridging the gap: exploring the causal relationship between metformin and tumors.Front Genet2024https://conductscience.org/library/papers/38962452PubMed
38929443Impacts of Dietary Standardized Ileal Digestible Lysine to Net Energy Ratio on Lipid Metabolism in Finishing Pigs Fed High-Wheat Diets.Animals (Basel)2024https://conductscience.org/library/papers/38929443PubMed
38627767Exosomes biogenesis was increased in metformin-treated human ovary cancer cells; possibly to mediate resistance.Cancer Cell Int2024https://conductscience.org/library/papers/38627767PubMed
38584203Chromatin modifiers in human disease: from functional roles to regulatory mechanisms.Mol Biomed2024https://conductscience.org/library/papers/38584203PubMed
38461424Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing.Aging (Albany NY)2024https://conductscience.org/library/papers/38461424PubMed
37698682Current status and frontier tracking of clinical trials on Metformin for cancer treatment.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37698682PubMed
37432627The Epigenetic Landscape of Meningiomas.Adv Exp Med Biol2023https://conductscience.org/library/papers/37432627PubMed
36959680Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells.Clin Epigenetics2023https://conductscience.org/library/papers/36959680PubMed
36875093The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment.Front Immunol2023https://conductscience.org/library/papers/36875093PubMed
36545268Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma.J Hepatocell Carcinoma2022https://conductscience.org/library/papers/36545268PubMed

See all 47 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29620187

GET https://conductscience.org/api/papers/v1/29620187/references?page=2